aluates Reports

$ 0.0

Automative

Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Research Report 2026

Published Date: 2026-02-03

Report Code: QYRE-Auto-30N18236

Global Isocitrate Dehydrogenase IDH Inhibitors Market Research Report 2024

BUY CHAPTERS

Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Research Report 2026

Code: QYRE-Auto-30N18236

Report

2026-02-03

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agios Pharmaceuticals

Bristol–Myers Squibb

Novartis

Bayer

Idenix Pharmaceuticals

Isocitrate Dehydrogenase (IDH) Inhibitors Market Size

The global Isocitrate Dehydrogenase (IDH) Inhibitors market was valued at US$ 642 million in 2025 and is anticipated to reach US$ 1376 million by 2032, at a CAGR of 11.7% from 2026 to 2032.

Isocitrate Dehydrogenase (IDH) Inhibitors Market

Isocitrate Dehydrogenase (IDH) Inhibitors are a class of targeted cancer therapies designed to inhibit the activity of mutated forms of isocitrate dehydrogenase enzymes, particularly IDH1 and IDH2. These enzymes play a crucial role in the citric acid cycle (Krebs cycle), and mutations in these genes can lead to the accumulation of oncometabolites like 2-hydroxyglutarate (2-HG), which contributes to tumorigenesis.

The North American market for Isocitrate Dehydrogenase (IDH) Inhibitors is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Isocitrate Dehydrogenase (IDH) Inhibitors is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Isocitrate Dehydrogenase (IDH) Inhibitors in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Isocitrate Dehydrogenase (IDH) Inhibitors include Agios Pharmaceuticals, Bristol-Myers Squibb, Idenix Pharmaceuticals, Novartis, Bayer AG, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Isocitrate Dehydrogenase (IDH) Inhibitors market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Isocitrate Dehydrogenase (IDH) Inhibitors. The Isocitrate Dehydrogenase (IDH) Inhibitors market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Isocitrate Dehydrogenase (IDH) Inhibitors market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Isocitrate Dehydrogenase (IDH) Inhibitors manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Isocitrate Dehydrogenase (IDH) Inhibitors Market Report

Report Metric	Details
Report Name	Isocitrate Dehydrogenase (IDH) Inhibitors Market
Accounted market size in 2025	US$ 642 million
Forecasted market size in 2032	US$ 1376 million
CAGR	11.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Oral Inhibitors Intravenous Inhibitors
Segment by Application	Hospital Research Center Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agios Pharmaceuticals, Bristol-Myers Squibb, Idenix Pharmaceuticals, Novartis, Bayer AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Isocitrate Dehydrogenase (IDH) Inhibitors companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Isocitrate Dehydrogenase (IDH) Inhibitors Market growing?

Ans: The Isocitrate Dehydrogenase (IDH) Inhibitors Market witnessing a CAGR of 11.7% during the forecast period 2026-2032.

What is the Isocitrate Dehydrogenase (IDH) Inhibitors Market size in 2032?

Ans: The Isocitrate Dehydrogenase (IDH) Inhibitors Market size in 2032 will be US$ 1376 million.

Who are the main players in the Isocitrate Dehydrogenase (IDH) Inhibitors Market report?

Ans: The main players in the Isocitrate Dehydrogenase (IDH) Inhibitors Market are Agios Pharmaceuticals, Bristol-Myers Squibb, Idenix Pharmaceuticals, Novartis, Bayer AG

What are the Application segmentation covered in the Isocitrate Dehydrogenase (IDH) Inhibitors Market report?

Ans: The Applications covered in the Isocitrate Dehydrogenase (IDH) Inhibitors Market report are Hospital, Research Center, Other

What are the Type segmentation covered in the Isocitrate Dehydrogenase (IDH) Inhibitors Market report?

Ans: The Types covered in the Isocitrate Dehydrogenase (IDH) Inhibitors Market report are Oral Inhibitors, Intravenous Inhibitors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral Inhibitors

1.2.3 Intravenous Inhibitors

1.3 Market by Application

1.3.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Research Center

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Perspective (2021–2032)

2.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Growth Trends by Region

2.2.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size by Region (2021–2026)

2.2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Region (2027–2032)

2.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market Dynamics

2.3.1 Isocitrate Dehydrogenase (IDH) Inhibitors Industry Trends

2.3.2 Isocitrate Dehydrogenase (IDH) Inhibitors Market Drivers

2.3.3 Isocitrate Dehydrogenase (IDH) Inhibitors Market Challenges

2.3.4 Isocitrate Dehydrogenase (IDH) Inhibitors Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players by Revenue

3.1.1 Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players by Revenue (2021–2026)

3.1.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Players (2021–2026)

3.2 Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue

3.4 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Concentration Ratio

3.4.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue in 2025

3.5 Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors Head Offices and Areas Served

3.6 Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Products and Applications

3.7 Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Isocitrate Dehydrogenase (IDH) Inhibitors Breakdown Data by Type

4.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size by Type (2021–2026)

4.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Type (2027–2032)

5 Isocitrate Dehydrogenase (IDH) Inhibitors Breakdown Data by Application

5.1 Global Isocitrate Dehydrogenase (IDH) Inhibitors Historic Market Size by Application (2021–2026)

5.2 Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)

6.2 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)

6.4 North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)

7.2 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)

7.4 Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)

8.2 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2021–2026)

8.4 Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)

9.2 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)

9.4 Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (2021–2032)

10.2 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2021–2026)

10.4 Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agios Pharmaceuticals

11.1.1 Agios Pharmaceuticals Company Details

11.1.2 Agios Pharmaceuticals Business Overview

11.1.3 Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Introduction

11.1.4 Agios Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

11.1.5 Agios Pharmaceuticals Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Details

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Introduction

11.2.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Idenix Pharmaceuticals

11.3.1 Idenix Pharmaceuticals Company Details

11.3.2 Idenix Pharmaceuticals Business Overview

11.3.3 Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Introduction

11.3.4 Idenix Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

11.3.5 Idenix Pharmaceuticals Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Introduction

11.4.4 Novartis Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

11.4.5 Novartis Recent Development

11.5 Bayer AG

11.5.1 Bayer AG Company Details

11.5.2 Bayer AG Business Overview

11.5.3 Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Introduction

11.5.4 Bayer AG Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

11.5.5 Bayer AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agios Pharmaceuticals

Bristol–Myers Squibb

Novartis

Bayer

Idenix Pharmaceuticals

List of Tables

Table 1. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral Inhibitors

Table 3. Key Players of Intravenous Inhibitors

Table 4. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million), 2021–2026

Table 7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region (2021–2026)

Table 8. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region (2027–2032)

Table 10. Isocitrate Dehydrogenase (IDH) Inhibitors Market Trends

Table 11. Isocitrate Dehydrogenase (IDH) Inhibitors Market Drivers

Table 12. Isocitrate Dehydrogenase (IDH) Inhibitors Market Challenges

Table 13. Isocitrate Dehydrogenase (IDH) Inhibitors Market Restraints

Table 14. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue by Players (US$ Million), 2021–2026

Table 15. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Players (2021–2026)

Table 16. Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Players by Tier (Tier 1, Tier 2, and Tier 3), based on Isocitrate Dehydrogenase (IDH) Inhibitors Revenue, 2025

Table 17. Ranking of Global Top Isocitrate Dehydrogenase (IDH) Inhibitors Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Headquarters and Area Served

Table 20. Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Products and Applications

Table 21. Global Key Players of Isocitrate Dehydrogenase (IDH) Inhibitors, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Type (US$ Million), 2021–2026

Table 24. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Type (2021–2026)

Table 25. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Type (2027–2032)

Table 27. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (US$ Million), 2021–2026

Table 28. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Application (2021–2026)

Table 29. Global Isocitrate Dehydrogenase (IDH) Inhibitors Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Isocitrate Dehydrogenase (IDH) Inhibitors Revenue Market Share by Application (2027–2032)

Table 31. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026

Table 33. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Country (US$ Million), 2027–2032

Table 46. Agios Pharmaceuticals Company Details

Table 47. Agios Pharmaceuticals Business Overview

Table 48. Agios Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product

Table 49. Agios Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026

Table 50. Agios Pharmaceuticals Recent Development

Table 51. Bristol-Myers Squibb Company Details

Table 52. Bristol-Myers Squibb Business Overview

Table 53. Bristol-Myers Squibb Isocitrate Dehydrogenase (IDH) Inhibitors Product

Table 54. Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026

Table 55. Bristol-Myers Squibb Recent Development

Table 56. Idenix Pharmaceuticals Company Details

Table 57. Idenix Pharmaceuticals Business Overview

Table 58. Idenix Pharmaceuticals Isocitrate Dehydrogenase (IDH) Inhibitors Product

Table 59. Idenix Pharmaceuticals Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026

Table 60. Idenix Pharmaceuticals Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Isocitrate Dehydrogenase (IDH) Inhibitors Product

Table 64. Novartis Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026

Table 65. Novartis Recent Development

Table 66. Bayer AG Company Details

Table 67. Bayer AG Business Overview

Table 68. Bayer AG Isocitrate Dehydrogenase (IDH) Inhibitors Product

Table 69. Bayer AG Revenue in Isocitrate Dehydrogenase (IDH) Inhibitors Business (US$ Million), 2021–2026

Table 70. Bayer AG Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

Table 74. Authors List of This Report

List of Figures

Figure 1. Isocitrate Dehydrogenase (IDH) Inhibitors Picture

Figure 2. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Type: 2025 vs 2032

Figure 4. Oral Inhibitors Features

Figure 5. Intravenous Inhibitors Features

Figure 6. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Application: 2025 vs 2032

Figure 8. Hospital Case Studies

Figure 9. Research Center Case Studies

Figure 10. Other Case Studies

Figure 11. Isocitrate Dehydrogenase (IDH) Inhibitors Report Years Considered

Figure 12. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region: 2025 vs 2032

Figure 15. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Players in 2025

Figure 16. Global Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Isocitrate Dehydrogenase (IDH) Inhibitors Revenue in 2025

Figure 18. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)

Figure 20. United States Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)

Figure 24. Germany Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Region (2021–2032)

Figure 32. China Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)

Figure 40. Mexico Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Isocitrate Dehydrogenase (IDH) Inhibitors Market Share by Country (2021–2032)

Figure 44. Israel Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Isocitrate Dehydrogenase (IDH) Inhibitors Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Agios Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

Figure 49. Idenix Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

Figure 50. Novartis Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

Figure 51. Bayer AG Revenue Growth Rate in Isocitrate Dehydrogenase (IDH) Inhibitors Business (2021–2026)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Dihydrowhey Dehydrogenase DHODH Inhibitor Market Research Report 2024

Ivosidenib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ivosidenib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global KRAS Inhibitor Market Research Report 2024

Global IDO Inhibitor Market Research Report 2024

Global Thymidylate Synthase Inhibitor Market Research Report 2024

Global CDK4 6 Inhibitors Market Research Report 2024

Global ALK Inhibitors Market Research Report 2024

Idhifa Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Indoximod Market Research Report 2024

Global Cyclin Dependent Kinase CDK Inhibitors Market Research Report 2025

Global Kinase Inhibitors For Cancer Treatment Market Research Report 2024

JAK1 Inhibitor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral CDK4 6 Inhibitors Market Research Report 2024

Tibsovo Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Succinate Dehydrogenase Inhibitor SDHI Market Research Report 2025

Global VEGF Inhibitors for Cancer Market Research Report 2024

Global VEGF Inhibitors Market Research Report 2024

Global Anti HER2 Therapy Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions